RTW Investments’s UroGen Pharma URGN Stock Holding History

RTW Investments’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$167M	Hold	4,543,895	–	–	1.43%	26
2026 Q1	$81.7M	Hold	4,543,895	–	–	0.81%	33
2025 Q4	$106M	Hold	4,543,895	–	–	1.07%	27
2025 Q3	$90.7M	Hold	4,543,895	–	–	1.12%	26
2025 Q2	$62.3M	Buy	4,543,895 +709,101	+18%	+$6.8M	0.89%	29
2025 Q1	$42.4M	Hold	3,834,794	–	–	0.65%	31
2024 Q4	$40.8M	Buy	3,834,794 +47,447	+1%	+$568K	0.62%	37
2024 Q3	$48.1M	Buy	3,787,347 +230,000	+6%	+$3.41M	0.7%	35
2024 Q2	$59.7M	Buy	3,557,347 +300,000	+9%	+$4.27M	0.92%	30
2024 Q1	$48.9M	Buy	3,257,347 +1,530,539	+89%	+$25M	0.72%	40
2023 Q4	$25.9M	Buy	1,726,808 +869,344	+101%	+$11.3M	0.4%	39
2023 Q3	$12M	Hold	857,464	–	–	0.25%	44
2023 Q2	$8.87M	Hold	857,464	–	–	0.17%	53
2023 Q1	$7.92M	Hold	857,464	–	–	0.17%	46
2022 Q4	$7.61M	Hold	857,464	–	–	0.16%	52
2022 Q3	$7.13M	Hold	857,464	–	–	0.16%	59
2022 Q2	$7.02M	Hold	857,464	–	–	0.18%	71
2022 Q1	$7.47M	Hold	857,464	–	–	0.15%	70
2021 Q4	$8.15M	Hold	857,464	–	–	0.12%	85
2021 Q3	$14.4M	Buy	+857,464	New	+$13.6M	0.22%	70

Other funds holding URGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

RTW Investments's URGN Position: Q2 2026 in Review

RTW Investments held its UroGen Pharma (URGN) position steady in Q2 2026 at 4,543,895 shares worth $167M. The position accounts for 1.43% of the portfolio, ranked #26.

RTW Investments first reported a position in URGN in Q3 2021 and has held it in 20 quarters since. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

RTW Investments held 4,543,895 shares of UroGen Pharma worth $167M as of Q2 2026.
RTW Investments left its UroGen Pharma share count unchanged in Q2 2026.
UroGen Pharma made up 1.43% of RTW Investments's portfolio in Q2 2026, its #26 holding.
RTW Investments first reported a position in UroGen Pharma in Q3 2021 and has held it in 20 quarters since.
189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.